Aims: To investigate psychotropic drug use among women ever exposed to intimate partner violence (IPV) in relation to mental distress and sociodemographic, lifestyle and somatic health characteristics, and to assess whether drug use differed for physical and/or sexual violence compared with psychological abuse alone. Methods: Cross-sectional data from women aged 30-60 years were drawn from self-reported questionnaires in the Oslo Health study [2000][2001]. Women reporting hypnotic, anxiolytic and/or antidepressant drug use in the previous four weeks were defined as users. Differences in psychotropic drug use by IPV exposure were examined by logistic regression analyses. Results: In total, 880 (14%) of 6,471 included women reported ever experiencing IPV; 494 (8%) reported physical and/or sexual IPV, and 386 (6%) reported psychological IPV alone. Physical and/or sexual IPV was significantly associated with use of all psychotropic drugs: hypnotics (odds ratio (OR) 2.28; 95% confidence interval (95% CI), 1.73-3.00); anxiolytics (OR 3.29; 95% CI, 2.43-4.44); and antidepressants (OR 2.72; 95% CI, 1.97-3.76). The associations remained significant for anxiolytics (OR 1.67; 95% CI, 1.14-2.45) and antidepressants (OR 1.50; 95% CI, 1.02-2.19) after adjusting for mental distress, sociodemographic, lifestyle and somatic health characteristics. Psychological IPV alone was associated with use of anxiolytics (OR 1.81; 95% CI, 1.20-2.75) and antidepressants (OR 2.38; 95% CI,. After adjustments the association persisted for use of antidepressants only (OR 1.64; 95% CI, 1.05-2.55). Conclusions: Women exposed to IPV were more likely to report use of psychotropic drugs, even after adjusting for mental distress. The study indicates that exposure to IPV; including psychological abuse should be evaluated as a possible source of distress when psychotropic drug treatment is considered.
Background
Intimate partner violence (IPV) refers to actual or threatened physical or sexual violence, or psychological abuse by a current or former intimate partner [1] . It is a prevalent form of violence against women; in a Norwegian study 27% of ever-partnered women reported ever experiencing IPV [2] ; across countries and populations the proportion varies from 10-71% [3, 4] . Moreover, an increasing body of research has shown relationships between IPV and several adverse physical and mental health outcomes [5] [6] [7] [8] .
Consequently, IPV has been recognized as an important contributor to ill-health among women and has been brought onto the agenda of public health. A wide range of mental health sequelae of IPV has been documented; the most prevalent being depression and post-traumatic stress disorder (PTSD) [6, 9, 10] .
Recent studies have indicated that psychotropic drug use is more prevalent among women exposed to IPV [2, 11, 12] . There is, however, a lack of knowledge about the pathway between IPV and psychotropic drug use; in particular how it is related to current mental health problems. If psychiatric disorders are recognized by a physician, they are often treated with psychotropic drugs [13] . However, most individuals with mental disorders remain undiagnosed or inadequately treated [14, 15] . On the other hand, psychotropic drugs are frequently prescribed for patients without psychiatric symptoms [16] . Thus, there is an incomplete relation between mental health and psychotropic drug use [17] . Indeed, several other factors, related to sociodemographic characteristics, lifestyle, and physical health, as well as mental distress, influence whether or not such drugs are prescribed [13, 16, 18, 19] .
The aims of this study were 1) to determine the prevalence among women participating in the Oslo Health Study of ever experiencing sexual, physical and psychological intimate partner violence, and the overlap between the different types of violence, and 2) to investigate psychotropic drug use among women ever exposed to IPV in relation to mental distress and sociodemographic, lifestyle and somatic health characteristics, and to assess whether drug use differed for physical and/or sexual violence compared with psychological abuse alone.
Material and methods
This is a population-based cross-sectional study. 25, 1940/41, 1955, 1960, and 1970 residing in Oslo in December 1999 were invited to fill in three self-administered questionnaires and to attend a health screening examination. Of the 40,888 invited citizens from the five original age groups, a total of 18,770 (46%) participated. Details on methodology are described elsewhere [20, 21] .
The main questionnaire and an invitation to attend a health screening were sent by mail two weeks prior to the screening. The main questionnaire covered sociodemographics, current health and mental distress, reported morbidity, family history of disease, risk factors and lifestyle, social support, use of health services, and use of medicine. Two supplementary questionnaires were handed out at the screening station: one was identical for all participants; the other came in four age-specific versions. English versions of the questionnaires are available at the web page of the Norwegian Institute of Public Health [20] . The supplementary questionnaires included several additional health conditions and health risks, and were filled in at home and returned by mail in a pre-paid envelope. Questions about violence were included in supplementary questionnaires given to women aged 30/45, 40 and 59/60 years at the screening station. These women represented the study sample.
Variables

Psychotropic drug use
Psychotropic drug use was assessed by the questions ''How often during the last four weeks have you taken (1) sleep medication, (2) tranquillizers and (3) antidepressants?'' Separate questions were included for each drug category. Response categories were ''daily'', ''every week, but not daily'', ''less often than every week'' and ''not taken the last four weeks''. Women who reported use of sleep medication, tranquillizers and/or antidepressants during the last four weeks were defined as users. Responders were informed that only drugs from pharmacies should be reported, not vitamins or nutritional supplements.
Intimate partner violence
Violence was assessed by the following questions: (a) ''Have you ever been systematically intimidated, degraded or humiliated over a longer period of time?'' (b) ''Have you ever experienced threats to harm you or someone close to you?'' (c) ''Have you ever been physically attacked/physically abused?'' (d) ''Have you ever been sexually abused?'' (e) ''Has anyone ever raped you or tried to rape you?'' Response categories were ''No'', ''Yes, below 18 years of age'' and ''Yes, 18 years or above''. Each question (a)-(e) contained separate questions on perpetrator (stranger, family/relative, partner, friend/acquaintance) and time of exposure (last 12 months, not last 12 months). Only violence for which the respondent indicated partner as perpetrator was defined as IPV. Psychological abuse was defined as having answered yes to question (a) and/or (b), physical violence as a positive response to question (c), and sexual violence as answering yes to question (d) and/ or (e). IPV was classified as physical and/or sexual IPV if the woman answered yes to question c, d and/ or e, as psychological IPV alone if she answered yes to question a and/or b, but not c-e, and No IPV (reference) if she answered no to all questions a-e. The questions on violence were extracted from a validated instrument developed by the Nordic Network on Violence and Health Research and applied in a five country study addressing gynaecological patients [22] .
Mental distress
Mental distress was measured by the Hopkins Symptoms Checklist-10 (HSCL-10) [23, 24] .
It consists of 10 items derived from the HSCL-25, primarily tapping symptoms of depression and anxiety during the previous week. Each item was scored on a scale of 1 (not at all) to 4 (extremely). The mean score was used as a measure of global mental distress. Cut off was set at a score of 1.85. Mental distress was classified as missing for records with three or more missing values on HSCL-10. If there were one or two missing values, they were replaced with the sample mean value for each item. The HSCL-10 has demonstrated high psychometric qualities in population-based studies [24] .
Other variables
Selection of other independent variables was based on factors associated with psychotropic drug use in former research, including age, education, paid employment, marital status, somatic disorder, daily cigarette smoking, alcohol use and mental distress. [13, 16, 17, 19] . Country of birth classified as Western or non-Western was also considered, but not included in multivariate analyses, as it was not significantly associated with psychotropic drug use in univariate analyses. The respondent was classified as having a somatic disorder if she reported at least one of the following conditions: chronic bronchitis/ emphysema, diabetes, asthma, osteoporosis, fibromyalgia/chronic pain syndrome, myocardial infarction, angina pectoris, cerebral haemorrhage/stroke, goitre, hyper-/hypothyroidism, thyroid cancer or chronic bowel disease.
Statistical analyses
Statistical analyses were based on Pearson Chisquare tests and logistic regression analyses performed with the SPSS statistical package, version 16.0. Independent variables significantly related (p 0.05) to psychotropic drug use in univariate analyses were included in multivariate models. Model 1 adjusted for age, education, paid employment, and marital status, model 2 for somatic disorder, alcohol use and cigarette smoking, model 3 for mental distress, and model 4 for all of the abovementioned. Separate analyses were performed for use of hypnotics, anxiolytics, antidepressants and any psychotropics. Crude and adjusted odds ratios (OR) with 95% confidence intervals were calculated by comparing psychotropic drug use among women who reported physical and/or sexual IPV and psychological IPV alone with women who reported no IPV (reference). Analyses were restricted to individuals with complete data on included variables.
Data on psychotropic drug use were missing for 386 (6.0 %) of the study sample. In the multivariate analyses between 742 (11.5 %) and 835 (12.9 %) were excluded because of missing data. Univariate analyses assessed whether individuals with missing data differed from responders according to IPV exposure and mental distress. There were statistically more missing data on hypnotic drug use among women who reported psychological IPV alone (16.3%) compared with women who reported no IPV (12.5%). No other significant differences were found.
Ethics
The study was conducted in accordance with the Helsinki Declaration. It was recommended by the Regional Committee for Medical Research Ethics. All participants gave written informed consent.
Results
A total of 16,926 women in the target age groups were invited to participate, of whom 8,094 (48%) attended the screening and hence received the questionnaire. Altogether, 6,808 women responded, of whom 334 were excluded because they did not answer any questions on violence. Thus our study group consisted of 6,471 women. Figure 1 shows the more often reported by women in the middle age group, who were divorced/separated, cigarette smokers, had a somatic disorder or high mental distress. Moreover, physical and/or sexual IPV was significantly more often reported by women with low education, no paid employment and frequent alcohol use. The latter characteristics were not statistically significant among women who reported psychological IPV alone. No significant differences were found for IPV by country of birth. Women who reported IPV were more often psychotropic drug users. However, the pattern of drug use differed; both types of IPV were significantly associated with use of anxiolytics, antidepressants and any psychotropics, while only physical and/or sexual IPV was associated with hypnotic drug use. Furthermore, these women had during the last 12 months significantly more often consulted a general practitioner (no IPV: 75.4%, psychological IPV alone: 81.7%, and sexual and/or physical IPV: 80.9%) or a psychiatrist/psychologist (no IPV: 7.5 %, psychological IPV alone: 17.5%; and sexual and/or physical IPV: 17.5%).
All variables in Table I except country of birth were significantly associated with all types of psychotropic drug use in univariate analyses, and consequently included in the multivariate analyses. Crude and adjusted odds ratios are presented in Table II . When adjusting for mental distress, the associations between physical and/or sexual IPV and psychotropic drug use were reduced, but remained significant for all drug types. Psychological IPV alone remained significantly associated with antidepressant drug use only. The latter association remained significant even when adjusting for sociodemographic characteristics, somatic disorder, substance use and mental distress. Concerning physical and/or sexual IPV, the associations remained significant for use of anxiolytics, antidepressants and any psychotropics, but not for hypnotic drug use.
Discussion
Women who reported IPV were more likely to use psychotropic drugs. However, the pattern of drug use differed by type of IPV. Physical and/or sexual IPV was associated with use of all psychotropic drugs. After adjusting for sociodemographic characteristics, somatic disorders, substance use and mental distress, the association ceased for hypnotics. Psychological IPV alone was associated with higher use of anxiolytics and antidepressants. In the adjusted analyses the difference persisted for use of antidepressants only. The strength of the study was the populationbased design, including women who might not have reported IPV exposure to health or legal services. Non-participation may, however, have influenced the results. A study of potential bias due to nonattendance showed a lower response rate among women with low socioeconomic status and poor health [21] . Since others have also found associations between IPV and low socioeconomic status and poor health, our findings may underestimate the true prevalence of IPV [2, [5] [6] [7] [8] 25 ]. An abusive partner may also have prevented women from participating in the study. Furthermore, reporting of violence depended on women's own definitions of physical and sexual abuse. This might have caused an underestimation of the prevalence of IPV, since women exposed to IPV do not necessarily define violent acts as abuse. In fact, large-scale general surveys have shown that IPV is under-reported [26] . On the other hand, women who have been exposed to IPV more often seek health services [27] ; and might possibly be more willing to participate in health surveys.
Our estimates of associations between IPV and psychotropic drug use might also have been affected by differential selection bias. Hospitalized women were not included in the study. Since they are more likely both to use psychotropic drugs and to have experienced IPV [28] , this may have rendered our estimates too conservative.
In accordance with current recommendations, analyses were based on lifetime exposure to IPV in order to cover long-term health consequences [26] . However; this may have introduced a bias, e.g. if women who suffered adverse health effects were more likely to remember and report IPV than exposed women in good health.
Due to a cross-sectional study design, we cannot infer that intimate partner violence preceded psychotropic drug use. Thus any causal relationships cannot be established. Moreover, the questions on violence did not cover severity or frequency, therefore we cannot assess whether there was a dose-response relationship between severity of the violence and psychotropic drug use. Psychotropic drug use was defined as any use over the last four weeks, and so potential differences in duration and efficacy of the psychotropic drug treatment between exposed and unexposed women would not have been detected. Furthermore, Hopkins Symptoms Checklist-10 primarily covers depression and anxiety. Other less prevalent mental disorders where psychotropic drugs might be indicated was thus not addressed in the study.
The prevalence of IPV was lower in this study compared with similar international studies [3, 4] as well as a Norwegian national survey of violence against women. The latter found an IPV prevalence of 27% among ever-partnered women [2] . Only 8% of the respondents were excluded because they had never had a partner, thus the fact that our study also included never-partnered women cannot fully explain the difference. However, the national survey used a more comprehensive violence questionnaire with a potentially higher sensitivity than the more general questions in our study [26] .
Former studies have often investigated only IPV comprising physical and/or sexual violence when assessing associations with health consequences [8, 29] . The present study showed that psychological IPV alone is both prevalent and associated with negative health outcomes. Consequently, all types of IPV including psychological IPV should be examined in future research.
Our study confirmed former findings of a higher probability of psychotropic drug use among women exposed to IPV [2, 12] , and additionally contributed with new information on possible pathways between IPV and psychotropic drug use. The adjusted analyses indicated that the association was partly related to differences in sociodemographic characteristics (model 1) and a higher prevalence of somatic disorder, cigarette smoking and alcohol use (model 2) among women reporting IPV. However, the strength of the association was most reduced when adjusting for mental distress (model 3). Still, our study showed that the association between IPV and psychotropic drug use could not be entirely explained by higher mental distress among women who reported IPV. Even when adjusting for all variables (model 4), associations persisted for antidepressant and anxiolytic drug use.
The association between IPV and psychotropic drug use may additionally be related to possible differences in use of health services or prescriber characteristics [17, 19] . It has indeed been shown that women reporting IPV more often seek health care [27] , which was also the case in the present study. This might have facilitated drug prescription. However, regular need for prescriptions may also have generated more frequent consultations. We were unable to go into more detail about this.
A new finding is that the pattern of hypnotic, anxiolytic and antidepressant drug use differed between women reporting physical and/or sexual IPV and psychological IPV alone. In general the associations were stronger for the former group. This might be due to a cumulative effect in the first group, as the majority of this group reported more than one type of violence [12] . The distinctions in pattern may furthermore reflect differences in morbidity not identified in the study, as the variables mental distress and somatic disorder were only approximate health measures. Moreover, hypnotic drug use is less related to psychiatric symptoms, excluding insomnia [16] .
Future studies should address psychotropic drug use in a longitudinal design to assess whether there are causal relationships between IPV exposure and psychotropic drug use. Since prescription of psychotropic drugs takes place in the healthcare system, improved knowledge on psychotropic drug use related to IPV exposure might facilitate better prevention of both IPV and subsequent adverse health consequences. Concern has been raised about the appropriateness of psychotropic drug prescribing practices [17] . The increased psychotropic drug use might reflect a higher probability of medication abuse and addiction [30] , as well as a lack of effective health care for women exposed to IPV. If IPV is overlooked, a possibly curable cause of distress would remain unrecognized. If so, psychotropic drug treatment might potentially be harmful, because all medications have side effects.
